Prosecution Insights
Last updated: October 27, 2026

Kenneth R Horlick, USPTO Patent Examiner

Listed by the USPTO as HORLICK, KENNETH R

Tech Center 1600 • Art Units: 1634 1637 1677 1681

This examiner grants 79% of resolved cases

Analysis

HORLICK, KENNETH R is assigned to Tech Center 1600 and Art Unit 1634. The record includes 1052 resolved cases, with a 79.0% allowance rate and a median of 899 days to allowance. The 15.3% interview lift indicates a higher allowance outcome for cases involving interviews in the recorded data.

Cellanome Inc., Singular Genomics Systems Inc., and California Institute of Technology are the listed companies. The listed firms are Bookoff McAndrews, PLLC, Casimir Jones, S.C., and FOLEY & LARDNER LLP. The allowance rate and case volume provide a substantial examiner-level reference for prosecution planning. Practitioners may consider interviews where they can resolve a defined issue, while the median timing supports maintaining a coordinated schedule for amendments, evidence, and client decisions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

79.0%
Allow Rate
+19.0% vs TC avg
1,084
Total Applications
+15.3%
Interview Lift
899
Avg Prosecution Days
Based on 1052 resolved cases, 2023–2026

Rejection Statute Breakdown

7.9%
§101 Eligibility
9.9%
§102 Novelty
28.3%
§103 Obviousness
35.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18419486 CHROMOPHORE-BASED MEDICAL SYSTEM FOR DETECTING GENETIC VARIATIONS IN ANALYTES Non-Final OA California Institute of Technology
19308103 METHODS AND SYSTEMS FOR PROCESSING CELL-FREE SAMPLES Final Rejection CareDx, Inc.
18494072 METHODS FOR FAST NUCLEIC ACID AMPLIFICATION Final Rejection University of Utah Research Foundation
17678357 GENE SIGNATURES FOR CANCER PROGNOSIS Non-Final OA MYRIAD GENETICS, INC.
18168131 FORCE-CONTROLLED NANOSWITCH ASSAYS FOR SINGLE-MOLECULE DETECTION IN COMPLEX BIOLOGICAL FLUIDS Non-Final OA Children's Medical Center Corporation
18029408 PATHOGEN DETECTION METHOD Non-Final OA Qiagen GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Kenneth R Horlick's allowance rate?

79.0% of resolved applications examined by Kenneth R Horlick were allowed (1,052 resolved cases), compared with 30.4% across Art Unit 1634 over the last five years.

Does an interview help with examiner Kenneth R Horlick?

This examiner's interview lift is +15.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Kenneth R Horlick take to allow a patent?

Applications allowed by Kenneth R Horlick took 899 days on average from filing to allowance.

Which art unit does examiner Kenneth R Horlick work in?

Kenneth R Horlick examines applications in Art Unit 1634 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month